Compare
Cencora, Inc. vs McKesson Corp vs Herbalife Ltd. vs Cosmos Health Inc.
| Latest fiscal year | Cencora, Inc. COR | McKesson Corp MCK | Herbalife Ltd. HLF | Cosmos Health Inc. COSM |
|---|---|---|---|---|
| Year ended | 2025-09-30 | 2026-03-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $321.33B | $403.43B | $5.04B | $65.27M |
| Revenue growth (YoY) | +9.3% | +12.4% | +0.9% | +19.9% |
| Gross margin | 3.6% | 3.6% | 77.9% | 12.1% |
| Operating margin | 0.8% | 1.5% | 9.5% | -25.6% |
| Net margin | 0.5% | 1.2% | 4.5% | -29.3% |
| Net income | $1.55B | $4.76B | $228.30M | -$19.14M |
| EPS (Diluted) | $7.96 | $38.38 | $2.20 | -$0.63 |
| Operating cash flow | $3.88B | $6.16B | $333.30M | -$8.45M |
| Free cash flow | $3.21B | $5.72B | $252.90M | -$8.50M |
| Cash & equivalents | $4.36B | $3.98B | $353.10M | $715.7K |
| Total assets | $76.59B | $82.32B | $2.79B | $65.48M |
| Total liabilities | n/a | n/a | $3.30B | $47.05M |
| Shareholders' equity | $1.51B | -$1.78B | -$515.10M | $18.42M |
| Return on year-end equity | 103.1% | n/a | n/a | -103.9% |
| Shares outstanding | 193.94M | n/a | 103.30M | 41.07M |
Revenue, most recent five fiscal years
| Fiscal year | Cencora, Inc. | McKesson Corp | Herbalife Ltd. | Cosmos Health Inc. |
|---|---|---|---|---|
| Latest | $321.33B Ended 2025-09-30 | $403.43B Ended 2026-03-31 | $5.04B Ended 2025-12-31 | $65.27M Ended 2025-12-31 |
| 1 year earlier | $293.96B Ended 2024-09-30 | $359.05B Ended 2025-03-31 | $4.99B Ended 2024-12-31 | $54.43M Ended 2024-12-31 |
| 2 years earlier | $262.17B Ended 2023-09-30 | $308.95B Ended 2024-03-31 | $5.06B Ended 2023-12-31 | $53.38M Ended 2023-12-31 |
| 3 years earlier | $238.59B Ended 2022-09-30 | $276.71B Ended 2023-03-31 | $5.20B Ended 2022-12-31 | $50.35M Ended 2022-12-31 |
| 4 years earlier | $213.99B Ended 2021-09-30 | $263.97B Ended 2022-03-31 | $5.80B Ended 2021-12-31 | $56.24M Ended 2021-12-31 |